Therefore, certain miRNAs, with cancer-, tissue- or organ-specific functions, might produce endocrine, paracrine or autocrine effect (41–44) on breast cancer patients, directly or indirectly regulating their response to NAT. The gene discussed is BRD2; the disease is cancer.